(r)-propafenone
Small moleculeexperimental
Clinical trial activity
3 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Oct 1, 2016 (NCT02710669)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- (r)-propafenone
- (r)-propafenone
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06096337 | N/A | Dec 15, 2023 | Boston Scientific Corporation, The Cleveland Clinic |
| NCT05939076 | Phase 3 | Aug 21, 2023 | Orebro University, Swedish Heart Lung Foundation, The Swedish Research Council, Uppsala University |
| NCT02710669 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2016 | National Heart, Lung, and Blood Institute (NHLBI), Vanderbilt University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | For profit | 1 | 1 | 1 | 2023 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 2016 |
| Orebro University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Swedish Heart Lung Foundation | Academic/Hospital | 1 | 0 | 1 | 2023 |
| The Cleveland Clinic | Academic/Hospital | 1 | 0 | 1 | 2023 |
| The Swedish Research Council | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Uppsala University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Vanderbilt University | Academic/Hospital | 1 | 1 | 1 | 2016 |
8 organizations
Page 1 / 1